Announcements Trials
Browse Landscape

Phase

Phase 1 49Phase 2 29Phase 1/2 22Phase 3 9Phase NA 4Phase EARLY_PHASE1 2Phase 4 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 21Plasma cell 10Other hematologic neoplasm 10Other solid neoplasm 5CNS 5Gynecologic 4Gastrointestinal 4Thoracic 3Sarcoma 3Head & Neck 3Dermatologic 3Genitourinary 2Breast 2Tumor-Agnostic 1Myeloid 1

Conditions

Uveal Melanoma 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Unknown Primary 1Neoplasms 1Metastatic Castration-resistant Prostate Cancer 1Melanoma 1Intraocular Lymphoma 1Esthesioneuroblastoma, Olfactory 1Colonic Neoplasms 1Chondrosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 13gallium 68 PSMA-11 8Fluorodeoxyglucose F18 5Specimen Handling 4Positron Emission Tomography Computed Tomography 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4enzalutamide 3Nivolumab 3Ipilimumab 3Interleukin-2 3Biopsy 368Ga-DKFZ-PSMA-11 3pembrolizumab 2pazopanib 2lenvatinib 2bicalutamide 2atezolizumab 2aldesleukin 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2X-Rays 2Standard of Care 2Radiation 2Positron-Emission Tomography 2Paclitaxel 2Oncolytic Virotherapy 2Nephrectomy 2Metformin 2Metastasectomy 2Immunoglobulin G 2Hydroxychloroquine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Cyclophosphamide × Genitourinary × Clear all
NCT03692663 2022-08-01

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
9 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT00499733 2019-01-18

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Terminated
19 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Chondrosarcoma, Colonic Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Osteosarcoma, Tongue Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Small Cell Lung Carcinoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡